|
LOC221710 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.106300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.771960E-01 |
| Normal-vs-Stage2 |
5.331600E-01 |
| Normal-vs-Stage3 |
1.729600E-02 |
| Normal-vs-Stage4 |
1.822310E-03 |
| Stage1-vs-Stage2 |
7.786200E-01 |
| Stage1-vs-Stage3 |
1.489170E-01 |
| Stage1-vs-Stage4 |
3.138200E-02 |
| Stage2-vs-Stage3 |
2.160200E-01 |
| Stage2-vs-Stage4 |
5.171800E-02 |
| Stage3-vs-Stage4 |
3.091200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.475900E-02 |
| Normal-vs-AfricanAmerican |
9.556000E-02 |
| Normal-vs-Asian |
1.972610E-01 |
| Caucasian-vs-AfricanAmerican |
6.344000E-01 |
| Caucasian-vs-Asian |
9.301600E-01 |
| AfricanAmerican-vs-Asian |
5.825800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.134490E-02 |
| Normal-vs-Female |
1.002190E-01 |
| Male-vs-Female |
1.799240E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.357200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.339800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.651600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.051600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.103300E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.826400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.185800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.418000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.493000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.744200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.374800E-01 |
| Classical-VS-Follicular |
7.75020000000071E-05 |
| Classical-VS-Other |
4.842800E-01 |
| Classical-VS-Normal |
5.468800E-01 |
| Tall-VS-Follicular |
2.925800E-01 |
| Tall-VS-Other |
9.509200E-01 |
| Tall-VS-Normal |
5.763800E-02 |
| Follicular-VS-Other |
5.174000E-01 |
| Follicular-VS-Normal |
2.791600E-04 |
| Other-VS-Normal |
2.853400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.137700E-03 |
| Normal-vs-N1 |
6.540400E-02 |
| N0-vs-N1 |
9.006600E-01 |
|
|
